J. Keith Joung

Active 1994–2025

117
Papers
55,741
Citations
91
h-index
116
i10-index

Citations

Citations per year for J. Keith Joung1970: 1 citations1992: 1 citations1994: 2 citations1995: 2 citations1996: 1 citations1997: 8 citations1998: 10 citations1999: 7 citations2000: 5 citations2001: 7 citations2002: 7 citations2003: 11 citations2004: 11 citations2005: 25 citations2006: 14 citations2007: 24 citations2008: 44 citations2009: 96 citations2010: 172 citations2011: 170 citations2012: 294 citations2013: 633 citations2014: 1,045 citations2015: 1,163 citations2016: 1,268 citations2017: 1,140 citations2018: 1,055 citations2019: 2,675 citations2020: 2,963 citations2021: 2,715 citations2022: 2,379 citations2023: 1,851 citations2024: 2,481 citations2025: 1,290 citations2026: 39 citations1971–1991: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,947 citing papers, 30.5% of this breakdownChina: 3,170 citing papers, 16.2% of this breakdownUnited Kingdom: 1,029 citing papers, 5.3% of this breakdownGermany: 1,012 citing papers, 5.2% of this breakdownJapan: 624 citing papers, 3.2% of this breakdownCanada: 557 citing papers, 2.9% of this breakdownIndia: 506 citing papers, 2.6% of this breakdownSouth Korea: 492 citing papers, 2.5% of this breakdownFrance: 490 citing papers, 2.5% of this breakdownItaly: 439 citing papers, 2.2% of this breakdownAustralia: 434 citing papers, 2.2% of this breakdownNetherlands: 426 citing papers, 2.2% of this breakdown
0%30.5%Other 22.5%

Fields

  • Biochemistry, Genetics and Molecular Biology76.1%
  • Medicine11.1%
  • Neuroscience6.1%
  • Agricultural and Biological Sciences2.1%
  • Immunology and Microbiology1.8%
  • Engineering0.7%
  • Other2.1%

Topics

  • CRISPR and Genetic Engineering19.8%
  • RNA and protein synthesis mechanisms4.6%
  • Advanced biosensing and bioanalysis techniques4%
  • RNA Interference and Gene Delivery3.7%
  • Virus-based gene therapy research3.2%
  • Pluripotent Stem Cells Research2.6%
  • Other62.1%

Coauthors

All papers

Open in search
  1. CRISPResso2 provides accurate and rapid genome editing sequence analysis

    Authors: , , , , , , , , , , - Nature Biotechnology 2019 cited by 1,819

  2. High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects

    Authors: , , , , , , - Nature 2016 cited by 2,738

  3. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases

    Authors: , , , , , , , , , , , - Nature Biotechnology 2014 cited by 2,307

  4. Gene therapy comes of age

    Authors: , , , , , - Science 2018 cited by 1,378

  5. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

    Authors: , , , , , , - Nature Biotechnology 2013 cited by 3,327

  6. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways

    Authors: , , , , , , , , , , , - Nature 2013 cited by 1,420

  7. Engineered CRISPR-Cas9 nucleases with altered PAM specificities

    Authors: , , , , , , , , , , , - Nature 2015 cited by 1,686

  8. CRISPR-Cas systems for editing, regulating and targeting genomes

    Authors: , - Nature Biotechnology 2014 cited by 3,178

  9. Enhanced proofreading governs CRISPR–Cas9 targeting accuracy

    Authors: , , , , , , , , , - Nature 2017 cited by 1,237

  10. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

    Authors: , , , , , , , , , - Nature Biotechnology 2014 cited by 1,471

  11. CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells

    Authors: , , , , , , , - Nature Biotechnology 2020 cited by 579

  12. Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing

    Authors: , , , , , , , , , , , , , - Nature Biotechnology 2019 cited by 724

  13. CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targets

    Authors: , , , , , - Nature Methods 2017 cited by 834

  14. Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors

    Authors: , , , , , , - Nature 2019 cited by 692

  15. Efficient genome editing in zebrafish using a CRISPR-Cas system

    Authors: , , , , , , , , - Nature Biotechnology 2013 cited by 3,003

  16. TALENs: a widely applicable technology for targeted genome editing

    Authors: , - Nature Reviews Molecular Cell Biology 2012 cited by 1,635

  17. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

    Authors: , , , , - Nature Biotechnology 2014 cited by 2,023

  18. High levels of AAV vector integration into CRISPR-induced DNA breaks

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 432

  19. CRISPR RNA–guided activation of endogenous human genes

    Authors: , , , , , - Nature Methods 2013 cited by 1,269

  20. Multidimensional control of therapeutic human cell function with synthetic gene circuits

    Authors: , , , , , , , , , - Science 2022 cited by 153

  21. An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities

    Authors: , , , , , , , - Nature Biotechnology 2018 cited by 451

  22. Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells

    Authors: , , , , , , , , - Nature Biotechnology 2016 cited by 714

  23. CRISPR DNA base editors with reduced RNA off-target and self-editing activities

    Authors: , , , , , , - Nature Biotechnology 2019 cited by 345

  24. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition

    Authors: , , , , , , - Nature Biotechnology 2015 cited by 630